Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontransmembrane receptor protein tyrosine phosphatase activity

PTPRC PTPRD PTPRF

6.34e-0517933GO:0005001
GeneOntologyMolecularFunctiontransmembrane receptor protein phosphatase activity

PTPRC PTPRD PTPRF

6.34e-0517933GO:0019198
GeneOntologyMolecularFunctionacid-amino acid ligase activity

TTLL9 TTL TTLL13

1.62e-0423933GO:0016881
DomainTTL

TTLL9 TTL TTLL13

2.99e-0513903PS51221
DomainTTL/TTLL_fam

TTLL9 TTL TTLL13

2.99e-0513903IPR004344
DomainTTL

TTLL9 TTL TTLL13

2.99e-0513903PF03133
Domainfn3

SDK2 PTPRC PTPRD PTPRF MYOM2 USH2A

1.32e-04162906PF00041
DomainFN3

SDK2 PTPRC PTPRD PTPRF MYOM2 USH2A

2.72e-04185906SM00060
DomainFN3

SDK2 PTPRC PTPRD PTPRF MYOM2 USH2A

4.02e-04199906PS50853
DomainATP_grasp_subdomain_2

TTLL9 TTL TTLL13

4.41e-0431903IPR013816
DomainFN3_dom

SDK2 PTPRC PTPRD PTPRF MYOM2 USH2A

5.21e-04209906IPR003961
DomainPTPc

PTPRC PTPRD PTPRF

6.89e-0436903SM00194
DomainTYR_PHOSPHATASE_PTP

PTPRC PTPRD PTPRF

8.72e-0439903PS50055
DomainPTPase_domain

PTPRC PTPRD PTPRF

1.01e-0341903IPR000242
DomainY_phosphatase

PTPRC PTPRD PTPRF

1.01e-0341903PF00102
DomainIg_I-set

SDK2 PTPRD PTPRF CILP MYOM2

2.26e-03190905IPR013098
DomainI-set

SDK2 PTPRD PTPRF CILP MYOM2

2.26e-03190905PF07679
DomainPTPc_motif

PTPRC PTPRD PTPRF

2.89e-0359903SM00404
DomainTyr_Pase_cat

PTPRC PTPRD PTPRF

2.89e-0359903IPR003595
DomainDUF1605

DHX16 DHX33

2.98e-0317902IPR011709
DomainOB_NTP_bind

DHX16 DHX33

2.98e-0317902PF07717
DomainHA2

DHX16 DHX33

3.34e-0318902SM00847
DomainHA2

DHX16 DHX33

3.34e-0318902PF04408
DomainHelicase-assoc_dom

DHX16 DHX33

3.34e-0318902IPR007502
DomainFd_Rdtase_FAD-bd

DUOX2 NOS1

3.72e-0319902IPR017927
DomainBAR

ARHGEF38 ACAP2

3.72e-0319902PS51021
DomainFAD_FR

DUOX2 NOS1

3.72e-0319902PS51384
DomainRiboflavin_synthase-like_b-brl

DUOX2 NOS1

3.72e-0319902IPR017938
DomainTyr_Pase_AS

PTPRC PTPRD PTPRF

5.28e-0373903IPR016130
Pubmed

Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.

PTPRC PTPRD PTPRF

7.08e-07796312376545
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

MRPS31 DHX16 ATP6V1A RBM22 KIF23 POLR2A MRPS9 DUOX2 UPF3B GLOD4 CDC73 EMC8 NDUFA4 OLA1 HNRNPAB GOT2

1.74e-061425961630948266
Pubmed

Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.

PTPRC PTPRD PTPRF

4.40e-06129639624153
Pubmed

The noncatalytic domains of Lck regulate its dephosphorylation by CD45.

PTPRC LCK

7.54e-06296212922168
Pubmed

Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling.

PTPRC LCK

7.54e-06296217897956
Pubmed

Beta-selection of immature thymocytes is less dependent on CD45 tyrosinephosphatase.

PTPRC LCK

7.54e-0629629870664
Pubmed

Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.

LCK GADD45GIP1

7.54e-06296225997448
Pubmed

CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes.

PTPRC LCK

7.54e-0629629581568
Pubmed

Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation.

LCK GADD45GIP1

7.54e-06296226210498
Pubmed

An activated epidermal growth factor receptor/Lck chimera restores early T cell receptor-mediated calcium response in a CD45-deficient T cell line.

PTPRC LCK

7.54e-0629628663450
Pubmed

Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR.

PTPRC PTPRF

7.54e-0629621695146
Pubmed

Partial USH2A deletions contribute to Usher syndrome in Denmark.

PCDH15 USH2A

7.54e-06296225804404
Pubmed

Expression of the p56(Lck) Y505F mutation in CD45-deficient mice rescues thymocyte development.

PTPRC LCK

7.54e-06296210330160
Pubmed

CD45RO regulates the HIV-1 gp120-mediated apoptosis of T cells by activating Lck.

PTPRC LCK

7.54e-06296229549706
Pubmed

Membrane-cytoskeleton interactions in cholesterol-dependent domain formation.

PTPRC LCK

7.54e-06296225658353
Pubmed

Expression of CD45 lacking the catalytic protein tyrosine phosphatase domain modulates Lck phosphorylation and T cell activation.

PTPRC LCK

7.54e-06296215687496
Pubmed

Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro.

PTPRC LCK

7.54e-0629628576115
Pubmed

Differential requirements of CD45 protein tyrosine phosphatase for cytolytic activities and intrathymic and extrathymic development of intestinal intraepithelial lymphocytes.

PTPRC LCK

7.54e-0629629725213
Pubmed

The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: cloning, characterization, and chromosomal localization.

PTPRD PTPRF

7.54e-0629627665159
Pubmed

Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56Lck regulates T-cell activation independently of Lck/CD45 interactions.

PTPRC LCK

7.54e-06296233225946
Pubmed

Lck-dependent tyrosine phosphorylation of diacylglycerol kinase alpha regulates its membrane association in T cells.

DGKA LCK

7.54e-06296218424699
Pubmed

GM1 controlled lateral segregation of tyrosine kinase Lck predispose T-cells to cell-derived galectin-1-induced apoptosis.

PTPRC LCK

7.54e-06296224231767
Pubmed

Phosphatase CD45 both positively and negatively regulates T cell receptor phosphorylation in reconstituted membrane protein clusters.

PTPRC LCK

7.54e-06296225128530
Pubmed

A Phosphosite within the SH2 Domain of Lck Regulates Its Activation by CD45.

PTPRC LCK

7.54e-06296228735895
Pubmed

Identification of intrinsic primary afferent neurons in mouse jejunum.

POLR2A NOS1

7.54e-06296232986284
Pubmed

Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes.

PTPRC LCK

7.54e-0629629973453
Pubmed

Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus.

PTPRC LCK

7.54e-06296215085197
Pubmed

An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation.

PTPRC LCK

7.54e-06296214749125
Pubmed

CD45-associated kinase activity requires lck but not T cell receptor expression in the Jurkat T cell line.

PTPRC LCK

7.54e-0629628473339
Pubmed

Biochemical analysis of the CD45-p56(lck) complex in Jurkat T cells lacking expression of lymphocyte phosphatase-associated phosphoprotein.

PTPRC LCK

7.54e-0629629533446
Pubmed

CD44-initiated cell spreading induces Pyk2 phosphorylation, is mediated by Src family kinases, and is negatively regulated by CD45.

PTPRC LCK

7.54e-06296211369760
Pubmed

Molecular genetics of successful smoking cessation: convergent genome-wide association study results.

PTPRD ARHGEF38 PCDH15 NRG3 USH2A

9.27e-0610196518519826
Pubmed

Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.

MRPS31 DMGDH VPS13D KIF23 ABCB7 TIMM21 POLG SELENOO MRPS9 GLOD4 NDUFA4 GADD45GIP1 GOT2

1.48e-051136961334800366
Pubmed

CD45 down-regulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells.

PTPRC LCK

2.26e-05396218981123
Pubmed

Regulation of Lck and Fyn tyrosine kinase activities by transmembrane protein tyrosine phosphatase leukocyte common antigen-related molecule.

PTPRF LCK

2.26e-05396212496362
Pubmed

Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45.

PTPRC LCK

2.26e-05396216709819
Pubmed

LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.

PTPRD PTPRF

2.26e-05396231985401
Pubmed

Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.

PTPRD PTPRF

2.26e-05396220139422
Pubmed

Chondroitin Sulfate Proteoglycans Negatively Modulate Spinal Cord Neural Precursor Cells by Signaling Through LAR and RPTPσ and Modulation of the Rho/ROCK Pathway.

PTPRD PTPRF

2.26e-05396225703008
Pubmed

Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.

PTPRD PTPRF

2.26e-0539629784606
Pubmed

Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.

PTPRD PTPRF

2.26e-05396233656439
Pubmed

CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases.

PTPRC LCK

2.26e-0539628175795
Pubmed

Genome-wide association study of copy number variations (CNVs) with opioid dependence.

PTPRC PTPRD

2.26e-05396225345593
Pubmed

T/B lineage choice occurs prior to intrathymic Notch signaling.

PTPRC DLL1

2.26e-05396215845899
Pubmed

Regulation of ATR activity via the RNA polymerase II associated factors CDC73 and PNUTS-PP1.

POLR2A CDC73

2.26e-05396230541148
Pubmed

Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase.

PTPRC LCK

2.26e-0539627507203
Pubmed

A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke.

ADAMTS12 TRIM29

2.26e-05396222990015
Pubmed

CD45 protein-tyrosine phosphatase associates with the WW domain-containing protein, CD45AP, through the transmembrane region.

PTPRC LCK

2.26e-0539627499298
Pubmed

CD45 signals outside of lipid rafts to promote ERK activation, synaptic raft clustering, and IL-2 production.

PTPRC LCK

2.26e-05396215661907
Pubmed

Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45.

PTPRC LCK

2.26e-05396210369126
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

MRPS31 ADAMTS12 RBM22 ARMC3 TIMM21 ZNF658 LMLN ZBTB21 MRPS9 DGKA DUOX2 MYOM2 EMC8 HNRNPAB

4.15e-051442961435575683
Pubmed

Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice.

TTLL9 TTLL13 AGBL3

4.49e-052596329593216
Pubmed

CD44 selectively associates with active Src family protein tyrosine kinases Lck and Fyn in glycosphingolipid-rich plasma membrane domains of human peripheral blood lymphocytes.

PTPRC LCK

4.51e-0549629573028
Pubmed

Aurora A drives early signalling and vesicle dynamics during T-cell activation.

POLR2A LCK

4.51e-05496227091106
Pubmed

Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism.

PCDH15 USH2A

4.51e-05496218463160
Pubmed

Impaired development of V gamma 3 dendritic epidermal T cells in p56lck protein tyrosine kinase-deficient and CD45 protein tyrosine phosphatase-deficient mice.

PTPRC LCK

4.51e-0549627807014
Pubmed

Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.

PTPRC LCK

4.51e-0549629403695
Pubmed

The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.

PTPRD PTPRF

4.51e-0549628524829
Pubmed

Integrin-mediated tyrosine phosphorylation of Shc in T cells is regulated by protein kinase C-dependent phosphorylations of Lck.

PTPRC LCK

4.51e-05496212589038
Pubmed

Substrate specificities and activities of AZAP family Arf GAPs in vivo.

ACAP2 ARAP1

4.51e-05496218003747
Pubmed

Anti-CD45 isoform antibodies enhance phagocytosis and gene expression of IL-8 and TNF-alpha in human neutrophils by differential suppression on protein tyrosine phosphorylation and p56lck tyrosine kinase.

PTPRC LCK

4.51e-05496212100025
Pubmed

Ezrin is a substrate for Lck in T cells.

PTPRC LCK

4.51e-05496212560083
Pubmed

Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

MRPS31 ATP6V1A VPS11 ABCB7 ATP2C1 HEATR6 MRPS9 OLA1 C1orf50 DIPK2A

4.56e-05754961033060197
Pubmed

TRIM65 regulates microRNA activity by ubiquitination of TNRC6.

POLR2A ZBTB21 UPF3B CDC73 OLA1 HNRNPAB GADD45GIP1

6.97e-0536496724778252
Pubmed

Staging and resetting T cell activation in SMACs.

PTPRC LCK

7.50e-05596212244310
Pubmed

Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.

PTPRD PTPRF

7.50e-05596210777529
Pubmed

Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis.

POLG GADD45GIP1

7.50e-05596227986797
Pubmed

Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.

PTPRD PTPRF

7.50e-05596222357843
Pubmed

Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2.

PCDH15 USH2A

7.50e-05596216301216
Pubmed

Association of CD45 with Lck and components of the Ras signalling pathway in pervanadate-treated mouse T-cell lines.

PTPRC LCK

7.50e-0559628570203
Pubmed

Selective regulation of Lyn tyrosine kinase by CD45 in immature B cells.

PTPRC LCK

7.50e-0559627499277
Pubmed

Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases.

PTPRD PTPRF

1.12e-04696219273906
Pubmed

Characterization of Lnk. An adaptor protein expressed in lymphocytes.

LCK NOS1

1.12e-0469629169414
Pubmed

Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria.

MRPS31 DMGDH ATP6V1A ABCB7 POLG EMC8 NDUFA4 GOT2

1.32e-0454296814651853
Pubmed

Modulation of apoptotic response by LAR family phosphatases-cIAP1 signaling during urinary tract morphogenesis.

PTPRD PTPRF

1.57e-04796229073098
Pubmed

Identification and typing of members of the protein-tyrosine phosphatase gene family expressed in mouse brain.

PTPRC PTPRF

1.57e-0479621454056
Pubmed

RNA polymerase II-associated factor 1 regulates the release and phosphorylation of paused RNA polymerase II.

POLR2A CDC73

1.57e-04796226659056
Pubmed

Biochemical characterization of native Usher protein complexes from a vesicular subfraction of tracheal epithelial cells.

PCDH15 USH2A

1.57e-04796220058854
Pubmed

Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation.

PTPRC LCK

1.57e-04796214625311
Pubmed

The parafibromin tumor suppressor protein is part of a human Paf1 complex.

POLR2A CDC73

1.57e-04796215632063
Pubmed

BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.

RBM22 GALM POLR2A UPF3B DHX33 TRIM29 GADD45GIP1

1.66e-0441996733001583
Pubmed

Microarray-based mutation analysis of 183 Spanish families with Usher syndrome.

PCDH15 USH2A

2.09e-04896219683999
Pubmed

UMD-USHbases: a comprehensive set of databases to record and analyse pathogenic mutations and unclassified variants in seven Usher syndrome causing genes.

PCDH15 USH2A

2.09e-04896218484607
Pubmed

Combinatorial expression of neurexins and LAR-type phosphotyrosine phosphatase receptors instructs assembly of a cerebellar circuit.

PTPRD PTPRF

2.09e-04896237591863
Pubmed

Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease.

PCDH15 USH2A

2.09e-04896216545802
Pubmed

Protein Tyrosine Phosphatase δ Mediates the Sema3A-Induced Cortical Basal Dendritic Arborization through the Activation of Fyn Tyrosine Kinase.

PTPRD PTPRF

2.09e-04896228637841
Pubmed

ABCE1 is a highly conserved RNA silencing suppressor.

ATP6V1A PTPRF TIMM21 NDUFA4 GADD45GIP1

2.62e-0420496525659154
Pubmed

The human PAF1 complex acts in chromatin transcription elongation both independently and cooperatively with SII/TFIIS.

POLR2A CDC73

2.68e-04996220178742
Pubmed

Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2.

PCDH15 USH2A

2.68e-04996223144817
Pubmed

Genetic modifiers of muscular dystrophy: implications for therapy.

SGCG NOS1

2.68e-04996216916601
Pubmed

The human PAF complex coordinates transcription with events downstream of RNA synthesis.

POLR2A CDC73

2.68e-04996216024656
Pubmed

The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II.

POLR2A CDC73

2.68e-04996215923622
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

JPH1 ATP6V1A ATP2C1 PTPRF TIMM21 CYP51A1 EMC8 MAPRE2 CEP97 DIPK2A

2.79e-04942961031073040
Pubmed

Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1.

PCDH15 USH2A

3.34e-041096224618850
Pubmed

Usher protein functions in hair cells and photoreceptors.

PCDH15 USH2A

3.34e-041096224239741
Pubmed

Real-time resolution of point mutations that cause phenovariance in mice.

PTPRC LCK

3.34e-041096225605905
Pubmed

A retrotransposon insertion in the 5' regulatory domain of Ptf1a results in ectopic gene expression and multiple congenital defects in Danforth's short tail mouse.

ARMC3 DLL1

3.34e-041096223437001
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

RBM22 KIF23 DSC3 POLR2A MAPRE2 HNRNPAB CEP97

3.42e-0447296738943005
Pubmed

Gene expression profile of the third pharyngeal pouch reveals role of mesenchymal MafB in embryonic thymus development.

PTPRC LCK DLL1

3.86e-045196319164599
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

MRPS31 DHX16 RBM22 HEATR6 POLR2A MRPS9 UPF3B HNRNPAB GOT2

4.00e-0480796922681889
GeneFamilyTubulin tyrosine ligase family

TTLL9 TTL TTLL13

1.50e-0514643779
GeneFamilyFibronectin type III domain containing

SDK2 PTPRC PTPRD PTPRF MYOM2 USH2A

2.15e-05160646555
GeneFamilyProtein tyrosine phosphatases, receptor type

PTPRC PTPRD PTPRF

5.38e-0521643813
GeneFamilyDEAH-box helicases

DHX16 DHX33

1.43e-0316642500
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

SDK2 PTPRD PTPRF MYOM2

2.54e-03161644593
GeneFamilyT cell receptor beta locus at 7q34

TRBV5-7 TRBV5-5 TRBV5-4

3.63e-0387643372
ToppCellCOVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations)

C1orf21 PTPRC RASA2 PLCL2 MYOM2 LCK

3.44e-06189966b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCelldroplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF23 PTPRF KCNK1 TRIM29 DLL1 SDC1

3.99e-0619496637803f4abf1aa1ad771c9cd293933003d7101e70
ToppCelldroplet-Tongue|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPRF DSC3 OLA1 TRIM29 SDC1 GOT2

4.11e-06195966e460b09ae354b579ce552acebdaa5877a6e62343
ToppCellFibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

ADAMTS12 C1orf21 PTPRD CILP ITGA10 TRIM29

4.24e-0619696624d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LRGUK AMPD3 KIF23 ARMC3 TTLL9 KCNK1

4.36e-06197966861e8df9bd74dc5e17bafdc1fb3fef546753c73a
ToppCellSkin|World / Skin and Kidney Cells in Lupus Nephritis Patients.

PTPRF DSC3 EXPH5 DGKA TRIM29 SDC1

4.62e-061999666be1340413ee868c610b6e3f58c65b493eb22bb5
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTPRF DSC3 UGT1A6 DGKA TRIM29 SDC1

4.62e-06199966ba284f984909504221900bca5ea12ada5b2ffd9f
ToppCellBiopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type

SDK2 DSC3 BEND5 UGT1A6 TRIM29 SDC1

4.76e-062009665cea84581201cee7ba8141b96e65864f4fd67113
ToppCellfacs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HGD LRGUK PCDH15 MMP8 USH2A

1.28e-0513996522a769d5195ed761ef333ef542746e1ba617a698
ToppCellfacs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HGD LRGUK PCDH15 MMP8 USH2A

1.28e-05139965292533e04178dd36d57377562077f9deb2cb9746
ToppCellLPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRGUK ARMC3 TTLL9 DUOX2 AK7

1.90e-0515196581cf939ed4df9574fbfff265e109cb9f947d7e6e
ToppCellLPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRGUK ARMC3 TTLL9 DUOX2 AK7

1.90e-051519659cbcbbc22965a9f0be8364e733d205dd64f2a533
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRGUK ARMC3 TTLL9 DUOX2 AK7

2.16e-051559655f1e2195a6b831e1b636f5cc3a282ca423721822
ToppCellLPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRGUK ARMC3 TTLL9 DUOX2 AK7

2.16e-051559650944429459f642a1bcc56edc1ec28aaecde3e2dc
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

RBM22 PTPRF SGCG NRG3 TSPYL4

2.30e-05157965f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCellwk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

JPH1 TRBV5-7 TRBV5-5 DGKA LCK

2.67e-05162965a27750117e7f16a0bd07cc5f58a56becb39e800b
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MRPS31 KIF23 LMLN PCDH15 MOSMO

3.76e-05174965e2243f1e48e3275753a2b3a69d06eefce69a8ded
ToppCelldroplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PTPRF KCNK1 ARHGEF38 ARHGAP8 SDC1

4.30e-05179965ca70a5518c5a5392e088c103e0cb44aa084f5332
ToppCelldroplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PTPRF KCNK1 ARHGEF38 ARHGAP8 SDC1

4.30e-05179965c451b074b04eb5d6c575c6abaedda579c6744bbf
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRF DSC3 DUOX2 TRIM29 SDC1

4.65e-05182965678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRF DSC3 DUOX2 TRIM29 SDC1

4.65e-051829658d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCellfacs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PTPRF DSC3 EXPH5 TRIM29 SDC1

4.90e-0518496545ff845ceed5960a997545c1009012b65e377d50
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9

SDK2 DSC3 TRIM29 ACAP2 DIPK2A

4.90e-05184965ea4ccebe2d54279fcc517e4f0bfa652b91a808bb
ToppCellfacs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PTPRF DSC3 EXPH5 TRIM29 SDC1

4.90e-051849652cc2646dee3c6001f7c10b7449c17d1935021958
ToppCell10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

C1orf21 PTPRC MYOM2 LCK MAPRE2

5.16e-05186965165d02be3b3eaeb8784a2b0b2020928b21a19bc7
ToppCellfacs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PTPRF KCNK1 ARHGEF38 ARHGAP8 SDC1

5.16e-05186965c7214e762b3b48197fdd0b36a50a4de2550a888f
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PTPRC GALM UGT1A6 DGKA LCK

5.43e-05188965e5c480b9a030536578f1cc91fb61738f752525b3
ToppCell343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

ATP2C1 TIMM21 ZBTB21 DIPK2A ARAP1

5.56e-05189965c26428871dc3261327d89cacaba6e21e004ff1f3
ToppCellIPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class

C1orf21 PTPRC MYOM2 LCK MAPRE2

5.56e-05189965d92e880162450f8d01e4b8784eb625275cb8e03e
ToppCelldroplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPRF KCNK1 ARHGEF38 SDC1 AK7

5.70e-05190965b057bea6e55cef872290893b6e439bbcdcee2f2e
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PTPRC GALM UGT1A6 DGKA LCK

5.85e-05191965c5e22df4a8741b8096cdd1618271fd48d6265846
ToppCellfacs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTPRF DSC3 EXPH5 TRIM29 SDC1

5.85e-05191965ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCelldroplet-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PTPRF KCNK1 ARHGEF38 SDC1 AK7

5.85e-051919651b59f1cad6c1a6a5938afa9195164918e3ff4e86
ToppCellnucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PTPRC PLCL2 MYOM2 LCK MAPRE2

5.99e-05192965a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SGCG DUOX2 USH2A TAF1L AK7

6.14e-05193965315840bc48899f3a36d57b19197509de19716e3d
ToppCellbackground-NK_cells|background / Sample and Cell Type and Tumor Cluster (all cells)

PTPRC PTPRD RASA2 PLCL2 MYOM2

6.14e-05193965f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCellE16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass

PTPRF EXPH5 KCNK1 ARHGAP8 SDC1

6.14e-05193965c1817ad675b9f9d2d3436c8b9646edf89f0d4c82
ToppCellE16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass

PTPRF EXPH5 KCNK1 ARHGAP8 SDC1

6.14e-051939651cb5a1cffa2b4a3bfecca16b791c1992edeb237d
ToppCellChildren_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

PTPRC RASA2 PLCL2 MYOM2 LCK

6.14e-051939651cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCell10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue

C1orf21 PTPRC MYOM2 LCK MAPRE2

6.45e-05195965e91e7f89163c615b706f3297b641b1e4c966f5e6
ToppCell3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MRPS31 ARMC3 TTLL9 DUOX2 AK7

6.45e-0519596579dc031258579ea328181dda33710dd897f1064a
ToppCell10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue

C1orf21 PTPRC MYOM2 LCK MAPRE2

6.45e-05195965a5a10ef9254c266316e5591bec19e159cc3caead
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DSC3 UGT1A6 TRIM29 DLL1 SDC1

6.61e-05196965c5adab88140a465698abcbedc6505a43cae7bfd1
ToppCellBasal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

SDK2 UGT1A6 TRIM29 DLL1 SDC1

6.61e-051969653b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTPRF DSC3 NDUFA4 TRIM29 SDC1

6.77e-051979658623972c7a70b3565b7a3a4afe93f1e012008201
ToppCellBasal_cells|World / lung cells shred on cell class, cell subclass, sample id

SDK2 UGT1A6 TRIM29 DLL1 SDC1

6.77e-0519796524360b660000bdfb999d58fbf4e29585a97e1785
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DSC3 UGT1A6 TRIM29 DLL1 SDC1

6.77e-05197965de772bd2b4cda843777ac879b1087e6444199dfb
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DSC3 TRIM29 HNRNPAB SDC1 GOT2

6.77e-051979652430f31d9312338e0ca23bfc6bdb0365340860fd
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DSC3 DUOX2 LCK TRIM29 SDC1

6.77e-051979659ee927d005eb17843e2516c8006eb192c6ad2af8
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

DSC3 BEND5 UGT1A6 TRIM29 SDC1

6.93e-05198965de5987588b9fa9ee8c595ba06d7d844ead0e3c74
ToppCellEpithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

SDK2 UGT1A6 DGKA TRIM29 DLL1

6.93e-051989654235005c49fc2b29ad3a0ee6b608f0109d04f775
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DSC3 DUOX2 LCK TRIM29 SDC1

6.93e-051989653371276410dba693c238b383d990b89371b14d8d
ToppCelldistal-Hematologic-CD4+_Memory/Effector_T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

PTPRC GALM RASA2 DGKA LCK

6.93e-051989657a89635f3567b4d2e6cd684c47be2e015d72a357
ToppCellNS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPRF EXPH5 KCNK1 DUOX2 TRIM29

6.93e-05198965a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCelldroplet-Skin-nan-21m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C1orf21 PTPRF DSC3 TRIM29 SDC1

6.93e-05198965e2d1ef4a4c89ce53b47d7d5b8a45e71d3117e1b1
ToppCelldroplet-Skin-nan-21m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C1orf21 PTPRF DSC3 TRIM29 SDC1

6.93e-0519896538a58e6eaae89ce1cadf2e04169c974e13587e50
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

DSC3 UGT1A6 TRIM29 DLL1 SDC1

7.10e-05199965995d710d7302272e7951a5a5d766d1039089ee2b
ToppCellPSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DSC3 BEND5 UGT1A6 DGKA SDC1

7.10e-051999652add64c3e4cb6384ec381f34c3f1f77e13e3f27c
ToppCellNS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

PTPRF EXPH5 KCNK1 DUOX2 TRIM29

7.10e-05199965b88a81cd2a89f4d27100c96ae4324dcee68daf83
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ARMC3 KCNK1 ARHGEF38 TRIM29 AK7

7.10e-051999658649c2380285a668782d75eb076ce548eed0911d
ToppCellBronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PTPRF EXPH5 ARHGEF38 TRIM29 SDC1

7.27e-05200965d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

PTPRF DSC3 EXPH5 TRIM29 SDC1

7.27e-0520096597f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellLPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ARMC3 KCNK1 ARHGEF38 DUOX2 AK7

7.27e-05200965da12821e8a0657869ca0f75d351cce2d7605a505
ToppCellTracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PTPRF DSC3 UGT1A6 TRIM29 SDC1

7.27e-05200965efd461c687155c84ef590352207e6fe4ba392a90
ToppCellParenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

DSC3 UGT1A6 TRIM29 DLL1 SDC1

7.27e-05200965592c7c3ded409a9957cbcdc62fcc213fa8eae598
ToppCellBiopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type

PTPRF EXPH5 KCNK1 ARHGEF38 SDC1

7.27e-052009651ef4d5ae698fa721e0f510bf0d918bd8d3b00591
ToppCellSkin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.

PTPRF DSC3 EXPH5 TRIM29 SDC1

7.27e-0520096559d72395199bc30df0e811fbc99149694e208860
ToppCellBiopsy_Other_PF-Immune-NK_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type

C1orf21 PTPRC MYOM2 LCK MAPRE2

7.27e-05200965418d665b8431697fc9e516258c9fe374257750d9
ToppCellBronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PTPRC RASA2 MYOM2 LCK MAPRE2

7.27e-05200965d1cfc4ef6ae75c486427e393d98b84a2a7ec67fe
ToppCellParenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

C1orf21 PTPRC MYOM2 LCK MAPRE2

7.27e-052009650a6fc7eff94e2f71af9f31a01779aafd2f4a6699
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DSC3 UGT1A6 TRIM29 DLL1 SDC1

7.27e-052009658cfbde43c5e66269ad128aa5398b1517667d7d36
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type.

PTPRC ARMC3 TTLL9 KCNK1 AK7

7.27e-05200965177f9ad8dd8635394c575a2b30140184df0bd51e
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

DSC3 UGT1A6 TRIM29 DLL1 SDC1

7.27e-0520096561811380d9252f12f27b7ad4752380b52692677f
ToppCellLPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ARMC3 KCNK1 ARHGEF38 DUOX2 AK7

7.27e-0520096572c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell367C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells)

NBEAL1 GADD45GIP1

1.25e-0489627e2e4c7bacc88c7bee10751805cb4caaf9da6aee
ToppCellLymphoid-T_cells_(Cd4+_Tnaive-Tcm)|World / shred on cell class and cell subclass (v4)

PTPRC DGKA LCK CEP97

1.91e-0413296414a371fc7e47a45b84f10a939163d030ad967de5
ToppCellStriatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32

ADAMTS12 GALM TTLL9 ITGA10

2.02e-04134964a3547a68012d879d4dfe80394eace70808722e43
ToppCellStriatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32

ADAMTS12 GALM TTLL9 ITGA10

2.02e-041349649458e2d0dbc18d9025b66b59f3ecc2fbc5384940
ToppCellfacs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ITGA10 TSPYL4 CEP97 AGBL3

2.59e-04143964b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7
ToppCellE18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

AMPD3 PTPRC CILP MMP8

2.73e-0414596488e463d5396a8fea2b7b1ecf3c9b144e16b35234
ToppCellE18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

AMPD3 PTPRC CILP MMP8

2.73e-04145964911fee7f27694393e348d94470a1a4e890038902
ToppCellP15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PTPRF KCNK1 ARHGEF38 SDC1

2.88e-04147964aba44c7057096483c4293a7ebcf8ccc8baed0231
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9

ADAMTS12 PTPRD CILP ARHGEF38

3.03e-041499643904f8ce9078de238600ceceee0116af52256a1c
ToppCellsaliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

PTPRC PLCL2 MYOM2 ARAP1

3.19e-04151964b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells)

PTPRC TRBV5-4 MYOM2 LCK

3.19e-04151964512f7f37ddc8dfa1906f7fff92b571929236c9ea
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PTPRC DGKA LCK GADD45GIP1

3.19e-0415196475c068b3e3aae5f9ba64d5fa5d1e2105a60e4293
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ARMC3 ARHGEF38 LCK NRG3

3.19e-04151964f4f7156b2c0cfc78fd1841e07c9915d97ced561f
ToppCellP15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

PTPRF KCNK1 ARHGEF38 SDC1

3.27e-0415296400d5503d462cfa009fb4cac79ecee11725a18b9a
ToppCellCOVID-19_Severe-CD8+_T_naive|World / disease group, cell group and cell class

EXPH5 DGKA LCK ARHGAP8

3.43e-04154964b568417d88a78d8c46688847f0f5f4989bd36387
ToppCellControl-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRGUK ARMC3 TTLL9 AK7

3.43e-041549644e3bc24043144143842627cacf6f90dda2228910
ToppCellControl-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRGUK ARMC3 TTLL9 AK7

3.43e-041549647556a4b2b062da5ae7ec2bbb66e745e7662db628
ToppCellfacs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

C1orf21 HYAL3 LCK NRG3

3.52e-04155964550e7e7e52829244ead829e5be010bfdc71e2ba5
ToppCellfacs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DMGDH PTPRD PTPRF SDC1

3.61e-04156964e2cda3ad4e5f44a80133864c5a38b766afb952ce
ToppCell5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DHX16 DMGDH SGCG DLL1

3.61e-04156964d411116d54add2d4fe649a97ac54cb94c085312f
ToppCell368C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

C1orf21 C16orf86 KCNK1 MYOM2

3.69e-04157964542944030cd9b3f3559e64f9f6598694d74003c0
ToppCellPND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

KIF23 PTPRC DGKA LCK

3.87e-04159964e9c51e611ebd427bbe51e3e036c14122c36ea372
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ABCB7 PTPRC DGKA LCK

3.87e-041599648d958d79f5eb3ab683d1245ae7f4f22a2cefbc55
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DUOX2 NRG3 TSPYL4 DIPK2A

3.87e-041599649f6607e395bcca9cb1c83199bdbbaaa62a93938d
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DUOX2 NRG3 TSPYL4 DIPK2A

3.87e-04159964c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

AMPD3 VPS13D PTPRC LCK

3.97e-04160964b2d8940ea8c068273b7da1589d3d6ae5110d8209
Diseasenon-alcoholic fatty liver disease severity measurement

PTPRD NRG3 ARHGAP8

8.51e-0528903EFO_0008421
DiseaseUsher Syndrome, Type II

PCDH15 USH2A

9.15e-055902C1568249
Diseasethrombin-antithrombin complex measurement

PTPRC KCNK1

5.95e-0412902EFO_0007775
DiseaseOpioid use measurement

PTPRD MYOM2

9.41e-0415902EFO_0009937
Diseasestroke

ADAMTS12 PTPRF NBEAL1 TRIM29

1.00e-03144904EFO_0000712
Diseasedecreased susceptibility to hepatitis C infection

PTPRD OFCC1

1.07e-0316902EFO_0010101
Diseaseobesity (biomarker_via_orthology)

PTPRF NOS1 SDC1 GOT2

1.08e-03147904DOID:9970 (biomarker_via_orthology)
Diseaseandrostenedione measurement, estrone measurement

PTPRD ARMC3

1.36e-0318902EFO_0007970, EFO_0007972
DiseaseFeeding difficulties

POLR2A GOT2

1.36e-0318902C0232466

Protein segments in the cluster

PeptideGeneStartEntry
DFDNQKVYAVYRGPE

BEND5

31

Q7L4P6
DQIKYYRNNPGQDGR

AGBL3

261

Q8NEM8
YVNYCNPELNQAGKG

C16orf86

196

Q6ZW13
IPAAYNRYDQERFKG

CDC73

286

Q6P1J9
LAEAQGQKGYVPANY

ARHGEF38

756

Q9NXL2
NIINDGFYDYGRINP

ARMC3

566

Q5W041
LYGQPGDETYQDIFR

ACAP2

741

Q15057
QIPQYLFEEGYTNKG

DHX16

431

O60231
GLQQDYIRKAEYPFS

ATP2C1

441

P98194
EDPEKYYLNGGFIIQ

ADAMTS12

746

P58397
GQNYYKEGPEGNDIR

AMPD3

716

Q01432
DILQGYPKDISNYGF

MMP8

356

P22894
KRPFGQSFVYIYDNG

NBEAL1

676

Q6ZS30
QNIKDRYYGINDPVA

RBM22

196

Q9NW64
YQGPQKEPDDYSNFV

RASA2

786

Q15283
GKYRQQGRNYIVEDG

OLA1

366

Q9NTK5
LQGGARVIFDDYKPY

PCDHB18P

6

Q96TA0
NPYFNSLEQKDLVGY

NRG3

576

P56975
GEPAKFYGYDNLQRQ

HOXD8

131

P13378
QKNPDSYNGAVRENY

NUDCD3

176

Q8IVD9
ETEAPGGYKFYLQNR

GLOD4

131

Q9HC38
YVPGEGYNQKFRELY

KCNK1

231

O00180
NQPEIFKNYGAEKYG

LMLN

506

Q96KR4
FYQPGPDYVKQRFQE

JPH1

416

Q9HDC5
YLQFQRPQGFEYKSG

DUOX2

1286

Q9NRD8
KYVQGDAIGYEGFQQ

DGKA

41

P23743
AKIFNYGRIYGAGQP

POLG

946

P54098
VPGKREQYGSVDQYA

HEATR6

1026

Q6AI08
YRPIDYGIFGKEQQL

EXPH5

1881

Q8NEV8
YKIRNLDNGGFYISP

LCK

181

P06239
RVDLYIKINQNFPGY

LRGUK

561

Q96M69
NSQLIRYAGYKQPDG

NOS1

481

P29475
SAEPKGNEYGRNYFD

OFCC1

81

Q8IZS5
DINKDFQPYYGEGGR

PCDH15

1336

Q96QU1
GYVFLDNKGQEYPAI

UPF3B

116

Q9BZI7
YGGQDVFLNNKYDRA

BECN2

336

A8MW95
ELEGYLQKQPYFGAV

GALM

61

Q96C23
NENGDAPGRYDIFQY

GRM6

461

O15303
NGYKAYDPENRNGNG

DSC3

491

Q14574
QDGKPYYAQIRGFIQ

GATAD1

161

Q8WUU5
GYIKNPYNIFDGVIV

CACNA1G

801

O43497
GFKARYPAVDYNLVQ

DLL1

631

O00548
GFYARNYNPQAKDVR

CEP97

571

Q8IW35
GKEYVLNRNRYGVEP

C19orf71

146

A6NCJ1
LNVKNVYFAQYGEPR

DIPK2A

86

Q8NDZ4
RYLQDNPASGEKFAY

CYP51A1

431

Q16850
DPQEQLYKAYTGFEQ

HYAL3

161

O43820
GKNYQNGDVFGDEYR

C1orf21

21

Q9H246
QYFNGAPVLYLEGRQ

DHX33

241

Q9H6R0
GFQGQQYILERGEYP

CRYBA4

61

P53673
RESYGFNNIVGYPKE

DMGDH

446

Q9UI17
FNNIVGYPKEERFAG

DMGDH

451

Q9UI17
NYDGKEYDPVEARQG

MAPRE2

161

Q15555
FLGPQNKETGRVYVY

ITGA10

511

O75578
QLGPRYAAKQFARYG

GADD45GIP1

51

Q8TAE8
GYYQANERVKDASPN

EMC8

91

O43402
PDAGRYYVQAVNDKN

SDK2

176

Q58EX2
PGNIYYLYKRESGQQ

C1orf50

116

Q9BV19
DGYRQQKAYIATQGP

PTPRF

1701

P10586
DGYRQQKAYIATQGP

PTPRD

1706

P23468
DRQVPGGYTVINKYQ

HGD

236

Q93099
TPEGYRLNRNGDYKE

KIF23

56

Q02241
IQFDEGYDNYPGQEK

MRPS31

226

Q92665
YNDKPFRQGDQVYAF

USH2A

556

O75445
YRPFYVNKGNGIGSN

TRIM29

571

Q14134
PKEVYQQQQYGSGGR

HNRNPAB

231

Q99729
LSNDEYYFPKQQGLR

TAF1L

586

Q8IZX4
YANENPGDFVNYNKR

PLCL2

656

Q9UPR0
LGPNDQYKFYSVNVD

NDUFA4

56

O00483
VVRDVFYDGNPKYEQ

SELENOO

226

Q9BVL4
YSLEEPKQANGGAYQ

SDC1

286

P18827
ERPENQYVYKIGIYG

SGCG

16

Q13326
FYEPQKGSIYLAGQN

ABCB7

521

O75027
NLGVGAYRDDNGKPY

GOT2

61

P00505
EGKYRRYHPLFGNQE

ARAP1

646

Q96P48
RSFYRQNGEPYIGKV

CILP

606

O75339
GPQFIFQYYEKEERG

TRBV5-5

61

A0A597
FQYYEKEERGRGNFP

TRBV5-5

66

A0A597
NKGNGQGEDRNLLYY

ZBTB21

296

Q9ULJ3
QDGVLYLYEQGKLFQ

VPS11

676

Q9H270
GRIKVNGIDYQLYFP

MRPS9

291

P82933
SQYPGAKYIIRDNGD

POLR2A

411

P24928
QGNPYFRNEGLVKEY

TSPYL4

301

Q9UJ04
KDDFLQQNGYTPYDR

ATP6V1A

516

P38606
GPQFIFQYYEKEERG

TRBV5-7

61

A0A0A0MS05
FQYYEKEERGRGNFP

TRBV5-7

66

A0A0A0MS05
GPQFIFQYYREEENG

TRBV5-4

61

A0A0C4DH59
FQYYREEENGRGNFP

TRBV5-4

66

A0A0C4DH59
RLYNQGKPVNFDDYG

ARHGAP8

276

P85298
LQAKGRVFRNPYNYG

ZDHHC16

311

Q969W1
QVKENPGSGEYDFRY

TIMM21

211

Q9BVV7
DEFLNQRYPGYFKVD

ZNF658

71

Q5TYW1
QRYIENPYLIGGRKF

TTLL9

211

Q3SXZ7
PYDQEELKNRYQSFG

UGT1A6

81

P19224
NYINASYIDGFKEPR

PTPRC

706

P08575
PGLVQLVNYYRGADK

TTL

56

Q8NG68
PADYGDFQSYGRQRK

TTLL13

181

A6NNM8
QGGTPIRYYFENLKI

VPS13D

3976

Q5THJ4
FYINEVGGQPYKLPN

MOSMO

121

Q8NHV5
QGYILDGFPKTYDQA

AK7

476

Q96M32
QAAEPGKYRIESNYG

MYOM2

196

P54296